- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03336996
Assessement the Reconstruction of Motor Circuits in Nerve Fiber Injuries After the Treatment of Umbilical Cord Mesenchymal Stem Cells With Blood Oxygen Level-dependent Drived Diffusion Tensor Imaging
November 6, 2017 updated by: General Hospital of Ningxia Medical University
Nowadays, the stem cell therapy is a promising method in treatment of the traumatic nerve fiber injuries.
And the clinical use of umbilical cord mesenchymal stem cells has been approved by FDA.
However, the results are inconsistent from both human study and animal research, it often difficult to visualize the reconstruction of the motor circuits.
A separate application of DTI could not precisely reveal white matter integrity.
Combining blood oxygen level-dependent(BOLD)-functional magnetic resonance imaging(fMRI) with diffusion tensor-based tractography (DTT), to detect neural activities in the brain involved in the motor function restore and then using the two seeds method to reconstruct the nerve fibers between these connecting regions.
The main aim of this study: i.
To characterize and evaluate functional and anatomical changes of nerve fiber injuries after umbilical cord mesenchymal stem cells transplantation with BOLD drived-diffusion tensor imaging(DTI).
ii.
To determine the therapeutic efficiency of umbilical cord mesenchymal stem cells and also the utility of the integration of BOLD-fMRI and DTI.
iii.
To correlate the imaging results with the electrophysiology outcomes.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
The stem cell therapy is a promising method in treatment of the traumatic nerve fiber injuries.
And the clinical use of umbilical cord mesenchymal stem cells has been approved by FDA.
However, the results are inconsistent from both human study and animal research, it often difficult to visualize the reconstruction of the motor circuits.
A separate application of DTI could not precisely reveal white matter integrity.
Combining BOLD-fMRI with diffusion tensor-based tractography (DTT), to detect neural activities in the brain involved in the motor function restore and then using the two seeds method to reconstruct the nerve fibers between these connecting regions.
The main aim of this study: i.
To characterize and evaluate functional and anatomical changes of nerve fiber injuries after umbilical cord mesenchymal stem cells transplantation with BOLD drived-DTI.
ii.
To determine the therapeutic efficiency of umbilical cord mesenchymal stem cells and also the utility of the integration of BOLD-fMRI and DTI.
iii.
To correlate the imaging results with the electrophysiology outcomes.
Study Type
Interventional
Enrollment (Anticipated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ningxia
-
Yinchuan, Ningxia, China, 750004
- General Hospital of Ningxia Medical University
-
Contact:
- Xia Hechun, M.D.
- Phone Number: 8613995109559
- Email: xHechun@nyfy.com.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- All tested patients must be Sobriety and coordination the examination.
- All tested patients with motor nerve fiber damaged must tally with the diagnosis standard which after the head CT, fMRI confirmation and obvious clinical symptoms.
- Patient's age and gender: 20-65years,the gender is not limit;
- All patient's must has one side neurological deficits.
- The patient must receive surgery and stem cell transplantation.
Exclusion Criteria:
- Progressive dysfunction;
- Other internal organs strict illness sickness, like serious heart disease, diabetes, liver, kidney vigorous sickness and so on;
- The patient with tumor in every system on there body;
- Having the primary or the sequential epilepsy medical history, within one year had the epileptic paroxysm;
- Can not accept MRI inspection, for some metal implant in there body(such as inner support in heart or brain blood vessel)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: evaluation
To characterize and evaluate functional and anatomical changes of nerve fiber injuries after umbilical cord mesenchymal stem cells transplantation with BOLD drived-DTI
|
All patients should be receive cranial BOLD-fMRI drived DTI scanning scanning separately before the transplant and after the transplant 0, 1, 3, 6 and 12 months.
|
Experimental: BOLD-fMRI and DTI
To determine the therapeutic efficiency of umbilical cord mesenchymal stem cells and also the utility of the integration of BOLD-fMRI and DTI.
|
the motor nerve fiber damaged patient receive a treatment course stem cell transplantation after the hematoma removal.
|
Experimental: correlate the imaging results
To correlate the imaging results with the electrophysiology outcomes
|
All patients should be receive cranial BOLD-fMRI drived DTI scanning scanning separately before the transplant and after the transplant 0, 1, 3, 6 and 12 months.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
BOLD-fMRI drived DTI scanning
Time Frame: After the transplant 6 months
|
All patients should be receive cranial BOLD-fMRI drived DTI scanning scanning after the transplant 6 months, and the result tells us that there is obvious reconstruction of motor circuits in nerve fiber on the damaged region;
|
After the transplant 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
FIM
Time Frame: after the transplant 6 months
|
All patients should receive the function independence evaluation (FIM) after the transplant 6 months , and the grading has the distinct improvement;
|
after the transplant 6 months
|
NIHSS
Time Frame: after the transplant 6 months
|
All patients should receive the American State-run Health Research institute apoplexy meter (NIHSS) evaluation after the transplant 6 months , and the grading has the distinct improvement;
|
after the transplant 6 months
|
Motor evoked potential
Time Frame: after the transplant 6 months
|
All patients should be receive motor evoked potential after the transplant 6 months, and the function of movement and sensation get obvious improvement;
|
after the transplant 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
March 1, 2018
Primary Completion (Anticipated)
March 1, 2020
Study Completion (Anticipated)
March 1, 2021
Study Registration Dates
First Submitted
October 26, 2017
First Submitted That Met QC Criteria
November 6, 2017
First Posted (Actual)
November 8, 2017
Study Record Updates
Last Update Posted (Actual)
November 8, 2017
Last Update Submitted That Met QC Criteria
November 6, 2017
Last Verified
October 1, 2017
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Xhechun4
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Characterize and Evaluate Functional After Transplantation
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedPersistent Pain After Injury | Functional Decline After InjuryUnited States
-
University of California, San FranciscoCompletedWound Complication | Functional Status After Sartorius Flap of the GroinUnited States
-
NovartisCompletedPrevention of Acute Rejection After Kidney Transplantation
-
NovartisCompletedPrevention of Acute Rejection After Kidney Transplantation
-
Gertrude J. Nieuwenhuijs-MoekeUnknownDelayed Graft Function | Renal Outcome After Kidney TransplantationDenmark, Netherlands, Spain
-
Ali YavuzcanAli Yavuzcan; Duygu Yıldız Birden; Alper BaşbuğCompletedThe Aim of Our Study Was to Evaluate the Outcomes in Women Who Implemented the Enhanced Recovery After Surgery Protocol at Delivery by Cesarean DeliveryTurkey
-
Seoul National University HospitalCompletedQuality of Life After Stem Cell TransplantationKorea, Republic of
-
Seoul National University HospitalRecruitingNew Onset Diabetes After TransplantationKorea, Republic of
-
RottapharmTerminatedHCV Recurrence After Liver Transplantation
-
University of ArizonaBristol-Myers SquibbUnknownKidney Transplantation | New Onset Diabetes After TransplantUnited States
Clinical Trials on BOLD-fMRI drived DTI scanning
-
University Hospital, Basel, SwitzerlandHeidelberg UniversityCompletedMyelomeningocele | Paraplegia, SpinalSwitzerland
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Massachusetts General HospitalAmerican Foundation for Suicide PreventionCompletedDepression | Bipolar Disorder | Suicidal IdeationUnited States
-
Hospices Civils de LyonUnknown
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell UniversityCompletedBrain CancerUnited States
-
University of BirminghamUniversity Hospital Birmingham; Birmingham and Solihull Mental Health NHS Foundation...Completed
-
Washington University School of MedicineCompletedNeural ConnectivityUnited States
-
Vanderbilt University Medical CenterVarian Medical SystemsRecruitingDepression | Obsessive-Compulsive Disorder | Pain, IntractableUnited States
-
Centre Hospitalier St AnneAssistance Publique - Hôpitaux de Paris; National Research Agency, France; CENIR... and other collaboratorsUnknown